‘NEUROSTEM-AD’ the treatment for Alzheimer’s disease requested for phase 1.2a clinical trials2013/06/28STEM CELL THERAPEUTIC
Mechanism of treatment for cartilage regeneration using stem cells, the first in the world2013/06/23STEM CELL THERAPEUTIC
MEDIPOST conducts the first procedure using the stem cell agent, CARTISTEM.2013/06/17STEM CELL THERAPEUTIC
MEDIPOST Enhances its Partnership with Canada’s OmniaBio in Collaboration for the CMDO Business of OmniaBio’s All-Around Cell and Gene Therapy.2022/12/01
Medipost to launch a CDMO business for cell and gene therapy products in Korea based on 20 years of research and production knowledge2022/10/17
Medipost enters North American market by acquiring OmniaBio, a CDMO company with cell and gene therapy products2022/05/31
